Your email has been successfully added to our mailing list.

×
0.0146376943358487 9.09173561232335E-05 -0.0471861078279844 -0.0148922629329939 -0.0162742067460678 0.012819347213383 0.0146376943358487 0.0146376943358487
Stock impact report

Spring Bank Announces Research Agreement with The National Institute of Allergy and Infectious Diseases to Evaluate HBV Antisense Oligonucleotide Compounds

SPRING BANK PHARMACEUTICALS (SBPH) 
Last spring bank pharmaceuticals earnings: 11/7 04:30 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.springbankpharm.com/investor-overview
Company Research Source: GlobeNewswire
HOPKINTON, Mass., July 18, 2019 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral infections, inflammatory diseases and certain cancers, today announced that it has entered into a research agreement with The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, to evaluate Spring Bank’s hepatitis B virus (HBV) antisense oligonucleotide compounds. Spring Bank has entered into a non-clinical evaluation agreement to access NIAID’s preclinical services program to further evaluate Spring Bank’s HBV antisense oligonucleotide compounds. Under the agreement, NIAID-funded contractors will evaluate Spring Bank’s lead compounds in the HBV transgenic mouse model, a well-established preclinical model to assess compound efficacy. NIAID has previously supported the evaluation of several of Spring Bank’s HBV antisense oligonucle Show less Read more
Impact Snapshot
Event Time:
SBPH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for SBPH alerts
Opt-in for
SBPH alerts

from News Quantified
Opt-in for
SBPH alerts

from News Quantified